NSE: MPHASIS | BSE: 526299

Strong Performer, Getting Expensive

Download real time

2904.20 -21.30 (-0.73%)

42.05% Gain from 52W Low

278.0K NSE+BSE Volume

NSE 12 Sep, 2025 3:31 PM (IST)

55,202.1

Market Cap

High in industry

1.4

Beta 1Year

Very High Volatility

MphasiS Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MPHASIS, BSE:526299 MphasiS Ltd.

MphasiS Ltd.

22 Jul 2023

2904.20

-0.73%

Mphasis (HOLD): Tepid Q1; cut to HOLD post runup

Hold: MphasiS Ltd.

Recommendation

BOB Capital Markets Ltd.

Q1 missed estimates as dollar revenue slipped 3.4% QoQ following a slowdown in both direct business and DXC

Number of FII/FPI investors decreased from 1016 to 986 in Jun 2025 qtr

MphasiS Ltd.

29 May 2023

2904.20

-0.73%

Mphasis (BUY): Dull quarter; sequential recovery guided from Q2

Buy: MphasiS Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Weak Q4 revenue print (-4.1% QoQ); DR and DXC remained a drag on growth

MphasiS Ltd. has an average target of 2878.40 from 5 brokers.

MphasiS Ltd.

02 May 2023

2904.20

-0.73%

Growth expected to come back in H2; margin resilient

Buy: MphasiS Ltd.

Target

Bonanza

Mphasis posted weak revenue print, yet maintained its margins. FY23 growth of 9.7% in cc terms was impacted by 4% from a decline in Digital Risk and 1.6% from a decline in DXC business. The increase in deal pipeline by 35% YoY including higher growth in non-BFSI deal pipeline is a sign of portfolio diversification and/or relative stress in BFSI (60% of revenue).

MphasiS Ltd. has an average target of 2878.40 from 5 brokers.

MphasiS Ltd.

02 May 2023

2904.20

-0.73%

Mphasis Limited

Hold: MphasiS Ltd.

Target

ICICI Direct

MphasiS Ltd. has an average target of 2878.40 from 5 brokers.

MphasiS Ltd.

29 Apr 2023

2904.20

-0.73%

Weakest growth profile among mid-tier peers on high mortgage/ BFSI exposure, Downgrade to Hold

Hold: MphasiS Ltd.

Target

ICICI Securities Limited

Mphasis has reported a revenue decline of -4.5% QoQ CC and -4.1% QoQ US$, much lower than our and consensus estimates (vs ISEC: -0.5% QoQ US$, BBG cons: -0.3% QoQ US$) in Q4FY23. Direct revenue growth declined 3.4% QoQ CC and DXC declined 24.8% QoQ CC.

MphasiS Ltd. is trading above all available SMAs

MphasiS Ltd.

29 Mar 2023

2904.20

-0.73%

MPHASIS LTD

Buy: MphasiS Ltd.

Target

Hem Securities

MphasiS Ltd. has gained 31.70% in the last 6 Months

MphasiS Ltd.

23 Jan 2023

2904.20

-0.73%

Mphasis Limited

Hold: MphasiS Ltd.

Recommendation Target

ICICI Direct

MphasiS Ltd. has an average target of 2878.40 from 5 brokers.

MphasiS Ltd.

23 Jan 2023

2904.20

-0.73%

Growth momentum expected to pick up in 2HCY23

Buy: MphasiS Ltd.

Bonanza

We find Mphasis much better placed compared to peers with a handle on its operating parameters and a risk reward that is tilted favourably (since MPHL is available at relatively cheaper valuations compared to peers).cheaper valuations compared to peers).

MphasiS Ltd. has an average target of 2878.40 from 5 brokers.

MphasiS Ltd.

22 Dec 2022

2904.20

-0.73%

Go-to-market strategy working well

Buy: MphasiS Ltd.

Bonanza

Before the breakout of the Covid-19 pandemic, Mphasis had underperformed its IT midcap peers by a margin because of volatility in DXC revenue stream. However, with Covid-19 breakout, there have been some changes in how business were operating.

MphasiS Ltd. is trading above all available SMAs

Is MphasiS Ltd. worth buying?

247 Votes:

Buy 78.95%

Sell 12.15%

Hold 8.91%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf